Related Experiment Videos
Tamoxifen therapy in steroid resistant Reidel's thyroiditis
M De1, A Jaap, J Dempster
1Crosshouse Hospital, Kilmarnock, Ayrshire. mrigankade@hotmail.com
Scottish Medical Journal
|June 8, 2001
Summary
Riedel's thyroiditis, a rare inflammatory condition causing thyroid fibrosis, was treated in a middle-aged woman. Corticosteroids and Tamoxifen proved effective, offering new therapeutic insights for this uncommon disease.
Area of Science:
- Endocrinology
- Immunology
- Oncology
Background:
- Riedel's thyroiditis is a rare, benign, chronic inflammatory disorder.
- It is characterized by extensive fibrosis of the thyroid gland and adjacent structures.
- The exact etiology remains unknown, but it is often associated with other fibrotic conditions.
Observation:
- A middle-aged female presented with goiter, stridor, and dyspnea, indicative of thyroid compression.
- Initial investigations suggested Riedel's thyroiditis.
- The patient experienced significant symptom relief with medical management.
Findings:
- The patient showed a positive response to corticosteroid therapy.
- Subsequent treatment with Tamoxifen led to further improvement.
- This case highlights the potential efficacy of both immunosuppressive and hormonal therapies.
Implications:
- Corticosteroids may help manage the inflammatory component of Riedel's thyroiditis.
- Tamoxifen's role warrants further investigation, potentially targeting fibrotic pathways.
- This case expands treatment options for Riedel's thyroiditis, improving patient outcomes.